Prothena Corporation plc [PRTA] stock is trading at $16.01, up 33.97%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PRTA shares have gain 15.93% over the last week, with a monthly amount glided 13.95%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Prothena Corporation plc [NASDAQ: PRTA] stock has seen the most recent analyst activity on January 30, 2024, when BofA Securities downgraded its rating to a Neutral and also revised its price target to $38 from $68. Previously, Deutsche Bank started tracking the stock with Buy rating on December 12, 2023, and set its price target to $62. On April 24, 2023, SVB Securities initiated with a Outperform rating and assigned a price target of $80 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $94 on January 27, 2023. RBC Capital Mkts downgraded its rating to a Sector Perform and raised its price target to $55 on November 04, 2022. BofA Securities upgraded its rating to Buy for this stock on September 28, 2022. In a note dated November 19, 2021, JMP Securities initiated an Mkt Outperform rating and provided a target price of $77 on this stock.
Prothena Corporation plc [PRTA] stock has fluctuated between $11.70 and $41.54 over the past year. Currently, Wall Street analysts expect the stock to reach $43 within the next 12 months. Prothena Corporation plc [NASDAQ: PRTA] shares were valued at $16.01 at the most recent close of the market. An investor can expect a potential return of 168.58% based on the average PRTA price forecast.
Analyzing the PRTA fundamentals
Prothena Corporation plc [NASDAQ:PRTA] reported sales of 133.35M for the trailing twelve months, which represents a drop of -98.86%. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -1.26%, Pretax Profit Margin comes in at -1.05%, and Net Profit Margin reading is -0.99%. To continue investigating profitability, this company’s Return on Assets is posted at -0.22, Equity is -0.24 and Total Capital is -0.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.92 points at the first support level, and at 9.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.38, and for the 2nd resistance point, it is at 20.75.
Ratios To Look Out For
For context, Prothena Corporation plc’s Current Ratio is 11.52. As well, the Quick Ratio is 11.52, while the Cash Ratio is 11.19. Considering the valuation of this stock, the price to sales ratio is 6.46, the price to book ratio is 1.61.
Transactions by insiders
Recent insider trading involved Walker Karin L, Chief Accounting Officer, that happened on Jan 24 ’24 when 5000.0 shares were sold. Chief Accounting Officer, Walker Karin L completed a deal on Dec 20 ’23 to sell 5000.0 shares.
